AstraZeneca strikes $40 million AI drug discovery deal with insitro

Reported by CNA Business (Asia) · Published 15 Oct 2026, 6:03 PM MYT (2 hr ago)

Summary

Source & full coverage: this summary is aggregated from CNA Business (Asia), the original publisher. Read the complete report for full context, data and quotes.

Read the original report at CNA Business (Asia) →

Most Recent

Stocks making the biggest moves premarket: CoreWeave, Rocket Lab Corp, SK Hynix & more 28 min ago Dollar eases from 18-month high as Treasury yields fall; Fed hike bets ease 31 min ago This 30-year market veteran is alarmed by a record-chasing S&P 500. Here’s where he’s investing instead. 32 min ago India's Tech Mahindra second-quarter revenue beats estimate 38 min ago Explainer-Why are credit default swaps unnerving AI investors? 41 min ago Venture Global inks deals with GE Vernova, Baker Hughes for power expansion 49 min ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

AstraZeneca strikes $40 million AI drug discovery deal with insitro

Summary

More in Asia

Dollar eases from 18-month high as Treasury yields fall; Fed hike bets ease

India's Tech Mahindra second-quarter revenue beats estimate

Explainer-Why are credit default swaps unnerving AI investors?

Venture Global inks deals with GE Vernova, Baker Hughes for power expansion

CoreWeave shares, bonds slide further as AI debt fears mount

Fintech firm Ramp raises $1.85 billion at $60 billion valuation